HeartCare Medical-B (06609.HK) Proposes to Extend Validity Period of Resolutions and Authorizations Relating to A-Share Issuance

HeartCare-B (06609) announced that the resolution and authorization regarding the A-share issuance were approved at the company's first extraordinary general meeting of 2022, the first H-share class general meeting of 2022, and the first domestic share and non-listed foreign investment share class general meeting of 2022, all held on November 9, 2022. The validity period for the resolution and authorization regarding the A-share issuance is 12 months from the date they were deliberated and approved at these meetings.

As of the date of this announcement, since the A-share issuance is still in progress and the validity period of the resolutions and authorization regarding the A-share issuance will expire on November 8, 2023, it is reasonable to propose extending the validity period of the resolutions and authorization for the A-share issuance by 12 months, considering the current progress of registration and the A-share issuance. The Board recommends extending the validity period of the resolutions and authorization for the A-share issuance by 12 months from the date of approval at the upcoming shareholders' general meeting, H-share class shareholders' meeting, and non-listed share class shareholders' meeting to ensure the continued progress of the A-share issuance.